ClearSign restarts $6,875,000 at-the-market program
ClearSign Technologies Corporation recommenced an at-the-market stock offering that allows it to sell up to $6,875,000 in common shares under an existing sales agreement with H.C.
Rhea-AI Filing Summary
ClearSign Technologies Corporation recommenced an at-the-market stock offering that allows it to sell up to $6,875,000 in common shares under an existing sales agreement with H.C. Wainwright & Co., LLC. These potential share sales are covered by a previously effective Form S-3 shelf registration.
The company filed a new prospectus supplement dated July 6, 2026 to restart this program and included a legal opinion from Mitchell Silberberg & Knupp LLP as an exhibit confirming the validity of the placement shares.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
ATM capacity: up to $6,875,000 in shares
Registration statement file number: File No. 333-288736
Shelf effectiveness date: July 28, 2025
+1 more
4 metrics
ATM capacity
up to $6,875,000 in shares
Maximum common stock that may be sold under at-the-market program
Registration statement file number
File No. 333-288736
Form S-3 shelf registration covering the placement shares
Shelf effectiveness date
July 28, 2025
Date Form S-3 registration statement was declared effective
Prospectus supplement date
July 6, 2026
Date of prospectus supplement recommencing the at-the-market program
Key Terms
at the market offering, prospectus supplement, Form S-3, At The Market Offering Agreement, +1 more
5 terms
at the market offering financial
"to recommence its “at the market” offering, as defined in Rule 415"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
prospectus supplement regulatory
"filed a prospectus supplement (the “Prospectus Supplement”) to recommence"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Form S-3 regulatory
"registration statement on Form S-3 (File No. 333-288736) filed"
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
At The Market Offering Agreement financial
"pursuant to that certain At The Market Offering Agreement between the Company"
An at-the-market offering agreement is a contract that lets a company sell newly issued shares directly into the open market through a broker, at whatever price the stock is trading at that moment. For investors this matters because it can increase the number of shares available (which may dilute existing ownership) while providing a flexible, often faster way for the company to raise cash without fixing a price, similar to a vendor selling small batches at current market stalls rather than setting a single fixed price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ClearSign Technologies (CLIR) disclose in this 8-K?
ClearSign Technologies disclosed that it has recommenced an at-the-market stock offering program, enabling sales of up to $6,875,000 in common shares under an existing agreement and a previously effective Form S-3 shelf registration.
How large is ClearSign Technologies’ at-the-market offering capacity?
The company may offer and sell up to $6,875,000 in shares of its common stock. This limit is defined in the prospectus supplement tied to its existing Form S-3 shelf registration and sales agreement with H.C. Wainwright & Co., LLC.
Which agreement governs ClearSign Technologies’ at-the-market sales?
The sales are governed by an At The Market Offering Agreement between ClearSign Technologies and H.C. Wainwright & Co., LLC. That agreement is dated July 17, 2025 and is used together with the new 2026 prospectus supplement for this program.
What legal opinion did ClearSign Technologies file with this disclosure?
ClearSign filed a legal opinion from Mitchell Silberberg & Knupp LLP as Exhibit 5.1. The opinion relates to the validity of the placement shares that may be issued under the at-the-market program described in the prospectus supplement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
